Javascript must be enabled to continue!
Review: Pancreatic β‐Cell Neogenesis Revisited
View through CrossRef
β‐cell neogenesis triggers the generation of new β‐cells
from precursor cells. Neogenesis from duct epithelium is the
most currently described and the best documented process
of differentiation of precursor cells into β‐cells. It is contributes
not only to β‐cell mass expansion during fetal and
nonatal life but it is also involved in the maintenance of the
β‐cell mass in adults. It is also required for the increase in
β‐cell mass in situations of increase insulin demand (obesity,
pregnancy). A large number of factors controlling the differentiation
of β‐cells has been identified. They are classified
into the following main categories: growth factors, cytokine
and inflamatory factors, and hormones such as PTHrP and
GLP‐1. The fact that intestinal incretin hormone GLP‐1
exerts a major trophic role on pancreatic β‐cells provides
insights into the possibility to pharmacologically stimulate
β‐cell neogenesis. This could have important implications
for the of treatment of type 1 and type 2 diabetes. Transdifferentiation,
that is, the differentiation of already differentiated
cells into β‐cells, remains controversial.However, more
and more studies support this concept. The cells, which can
potentially “transdifferentiate” into β‐cells, can belong to
the pancreas (acinar cells) and even islets, or originate from
extra‐pancreatic tissues such as the liver. Neogenesis from intra‐islet precursors also have been proposed and subpopulations
of cell precursors inside islets have been described
by some authors. Nestin positive cells, which have been considered
as the main candidates, appear rather as progenitors
of endothelial cells rather than β‐cells and contribute to
angiogenesis rather than neogenesis. To take advantage of
the different differentiation processes may be a direction for
future cellular therapies. Ultimately, a better understanding
of the molecular mechanisms involved in β‐cell neogenesis
will allow us to use any type of differentiated and/or undifferentiated
cells as a source of potential cell precursors.
Title: Review: Pancreatic β‐Cell Neogenesis Revisited
Description:
β‐cell neogenesis triggers the generation of new β‐cells
from precursor cells.
Neogenesis from duct epithelium is the
most currently described and the best documented process
of differentiation of precursor cells into β‐cells.
It is contributes
not only to β‐cell mass expansion during fetal and
nonatal life but it is also involved in the maintenance of the
β‐cell mass in adults.
It is also required for the increase in
β‐cell mass in situations of increase insulin demand (obesity,
pregnancy).
A large number of factors controlling the differentiation
of β‐cells has been identified.
They are classified
into the following main categories: growth factors, cytokine
and inflamatory factors, and hormones such as PTHrP and
GLP‐1.
The fact that intestinal incretin hormone GLP‐1
exerts a major trophic role on pancreatic β‐cells provides
insights into the possibility to pharmacologically stimulate
β‐cell neogenesis.
This could have important implications
for the of treatment of type 1 and type 2 diabetes.
Transdifferentiation,
that is, the differentiation of already differentiated
cells into β‐cells, remains controversial.
However, more
and more studies support this concept.
The cells, which can
potentially “transdifferentiate” into β‐cells, can belong to
the pancreas (acinar cells) and even islets, or originate from
extra‐pancreatic tissues such as the liver.
Neogenesis from intra‐islet precursors also have been proposed and subpopulations
of cell precursors inside islets have been described
by some authors.
Nestin positive cells, which have been considered
as the main candidates, appear rather as progenitors
of endothelial cells rather than β‐cells and contribute to
angiogenesis rather than neogenesis.
To take advantage of
the different differentiation processes may be a direction for
future cellular therapies.
Ultimately, a better understanding
of the molecular mechanisms involved in β‐cell neogenesis
will allow us to use any type of differentiated and/or undifferentiated
cells as a source of potential cell precursors.
Related Results
Complex Collision Tumors: A Systematic Review
Complex Collision Tumors: A Systematic Review
Abstract
Introduction: A collision tumor consists of two distinct neoplastic components located within the same organ, separated by stromal tissue, without histological intermixing...
Frequency of Common Chromosomal Abnormalities in Patients with Idiopathic Acquired Aplastic Anemia
Frequency of Common Chromosomal Abnormalities in Patients with Idiopathic Acquired Aplastic Anemia
Objective: To determine the frequency of common chromosomal aberrations in local population idiopathic determine the frequency of common chromosomal aberrations in local population...
β-Cell Neogenesis During Prolonged Hyperglycemia in Rats
β-Cell Neogenesis During Prolonged Hyperglycemia in Rats
β-cell neogenesis from ductal precursors, and possibly from other pancreatic cell types, contributes to the expansion of β-cell mass during development and after diabetogenic insul...
Abstract IA-08: Clinical advances in pancreas adenocarcinoma
Abstract IA-08: Clinical advances in pancreas adenocarcinoma
Abstract
Pancreatic adenocarcinoma (PDAC) remains one of the most lethal cancers today and is expected to be the second cause of cancer death in the coming decade. M...
Abstract 1603: Intra-pancreatic fat promotes the progression of PDAC by activating thermogenesis
Abstract 1603: Intra-pancreatic fat promotes the progression of PDAC by activating thermogenesis
Abstract
Background: The presence of minimal intra-pancreatic fat deposition (IPFD) in the healthy human pancreas has been demonstrated in numerous studies. But exce...
Abstract 1695: Imaging of the interaction of pancreatic cancer and stellate cells during liver metastasis
Abstract 1695: Imaging of the interaction of pancreatic cancer and stellate cells during liver metastasis
Abstract
Pancreatic stellate cells are involved in fibrosis of pancreatic cancer. An understanding of pancreatic cancer-cell interactions with stellate cells is crit...
High KLK7 Expression Predicts Unfavorable Outcomes in Patients with Resectable Pancreatic Ductal Adenocarcinoma
High KLK7 Expression Predicts Unfavorable Outcomes in Patients with Resectable Pancreatic Ductal Adenocarcinoma
Abstract
Background Studies have shown that kallikrein-related peptidase 7 (KLK7) is abnormally expressed in a various of tumours and plays a crucial role in tumour progres...
Activated Pancreatic Stellate Cells Enhance the Warburg Effect to Cause the Malignant Development in Chronic Pancreatitis
Activated Pancreatic Stellate Cells Enhance the Warburg Effect to Cause the Malignant Development in Chronic Pancreatitis
Abstract
Background: Chronic pancreatitis (CP) is a precancerous condition associated with pancreatic ductal adenocarcinoma (PDAC), but its evolutionary mechanism is unclea...

